Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elekta AB (EKTAY)
OTHER OTC:EKTAY
Holding EKTAY?
Track your performance easily
Earnings Data
Report Date
Feb 21, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
―Last Year’s EPS
$0.08Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 27, 2024
|% Change Since: -3.31%
|Next Earnings Date:Feb 21, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted positive developments such as growth in the U.S. market and successful product launches, but these were overshadowed by significant sales declines and margin pressures, particularly in Europe and Latin America. The outlook for China was cautiously optimistic, yet concerns remain about geopolitical risks and macroeconomic challenges.Company Guidance
In the Q2 2025 earnings call for Elekta, the guidance highlighted several key metrics and developments. Net sales decreased by 4% in constant currencies, with growth in the U.S. offset by declines in Europe and Latin America. The gross margin was reported at 35.7%, a decline attributed to reduced net sales, market mix changes, particularly increased volumes in Ukraine, and a 90 basis point negative impact from foreign exchange rates. The adjusted EBIT margin fell to 9.8%, influenced by gross margin developments and higher amortization costs from recent product launches. Despite these challenges, the book-to-bill ratio was 0.99 for the quarter, with a rolling 12-month ratio of 1.09, indicating a strong foundation for future sales growth. Elekta's new product launches, including the Elekta Evo and Elekta ONE Planning, have been positively received, with ongoing installations in Europe and a recent submission to the U.S. FDA for premarket approval. The company has also reached its target of providing radiation therapy access to 300 million people in underserved markets ahead of schedule. Looking forward, Elekta anticipates mid-single-digit sales growth for the full year and aims for an EBIT margin expansion to 14% and higher beyond 2024-2025.Growth in U.S. Market
Despite challenges in other regions, the U.S. market showed growth in the quarter.
Elekta Evo Product Launch
Successful launch of Elekta Evo and Elekta ONE Planning with positive customer feedback and ongoing installations in Europe.
Achievement in Underserved Markets
Elekta reached its target to provide radiation therapy access to 300 million people in underserved markets six months ahead of schedule.
China Market Improvement
The Chinese market showed improved order development with strong double-digit growth on the order side.
---
EKTAY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EKTAY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 27, 2024 | $5.74 | $5.93 | +3.31% |
| Aug 28, 2024 | $6.72 | $6.78 | +0.89% |
| Jun 05, 2024 | $8.04 | $6.60 | -17.91% |
| Feb 29, 2024 | $7.04 | $7.18 | +1.99% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Elekta AB (EKTAY) report earnings?
Elekta AB (EKTAY) is schdueled to report earning on Feb 21, 2025, TBA Not Confirmed.
What is Elekta AB (EKTAY) earnings time?
Elekta AB (EKTAY) earnings time is at Feb 21, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EKTAY EPS forecast?
Currently, no data Available
---